Yahoo Web Search

Search results

  1. Peter Lengyel Reflecting the growing interest from both consumers and policymakers, and building on recent developments in Willingness to Pay (WTP) methodologies, we evaluate consumer...

  2. Principal Investigator: E. Lengyel Title: “Understanding Molecular Differences between Low-Grade Serous Ovarian Cancer and High-Grade Serous Ovarian Cancer and Study if the Novel Targets Can Be Used for Therapy”

  3. Apr 27, 2020 · Peter Lengyel, PhD, professor emeritus of molecular biophysics and biochemistry, passed away on April 21, 2020. He was known for his tremendous recall and vast.

  4. Peter. Lengyel, Emeritus Professor, Department of Molecular Biophysics and Biochemistry, Yale Uni-versity, and who joined the Department in 1965, passed away at his home in Woodbridge Connecticut on April 21, 2020. He was 91 years old.

  5. Oct 30, 2011 · Abstract. Intra-abdominal tumors, such as ovarian cancer, have a clear predilection for metastasis to the omentum, an organ primarily composed of adipocytes.

  6. Oct 7, 2016 · In this model, the PAX8 promoter, specific to secretory fallopian tube epithelial cells (FTECs), was used to inactivate BRCA1 (Breast Cancer 1; germline mutations in BRCA1/2 occur in about 13% of HGSOCs) and PTEN and drive expression of mutant TP53.

  7. Apr 27, 2020 · Peter Lengyel, PhD, died peacefully at his home in Woodbridge, Conn. on April 21, attended by his son Michael and his daughter Carole. Peter Lengyel was a beloved colleague and a highly respected member in the Molecular Biophysics and Biochemistry department at Yale University.